What dose constraints should be applied to the uninvolved liver during stereotactic body radiation therapy (SBRT) in an adult with preserved liver function (Child‑Pugh A) and 3–5 treatment fractions?

Uninvolved Liver Dose Constraints for SBRT in Child-Pugh A Patients (3-5 Fractions)

For patients with Child-Pugh A liver function receiving 3-5 fraction SBRT, ensure that at least 700-800 cm³ of uninvolved liver receives less than 15-18 Gy to prevent hepatic decompensation and maintain adequate liver function.

Primary Dose Constraints

The most critical constraint for uninvolved liver during SBRT is volumetric rather than mean dose-based:

• ≥700 cm³ of total liver must be spared from the 15 Gy isodose 1
• ≥800 cm³ of total liver receiving <18 Gy is the threshold identified to reduce risk of Child-Pugh class progression 2

The 800 cm³ threshold at <18 Gy represents the strongest evidence-based constraint, derived from multivariate analysis showing this was the only significant parameter predicting Child-Pugh class deterioration after SBRT 2. This is clinically critical because progression of Child-Pugh class limits subsequent treatment options and reflects meaningful hepatic functional decline.

Additional Volumetric Considerations

Beyond the primary constraint, consider these parameters based on tumor and patient characteristics:

• Mean liver dose: Keep as low as reasonably achievable, ideally <13 Gy for 5-fraction regimens 2
• Normal liver volume (total liver minus GTV): Should exceed 1,148 cm³ to minimize ≥Grade 2 hepatic adverse reactions 3
• Total liver volume: Should exceed 1,162 cm³ when using 45 Gy in 3 fractions 3

Fractionation-Specific Guidance

The dose constraints must be adjusted based on fractionation scheme:

For 3-fraction regimens (30-39 Gy total):

• Prioritize the 700-800 cm³ receiving <15-18 Gy constraint
• More stringent adherence required due to higher dose per fraction
• Ensure adequate uninvolved liver volume (>1,148 cm³) 3

For 5-fraction regimens (typically 30-50 Gy total):

• Same volumetric constraints apply
• Slightly more flexibility in mean liver dose
• Standard constraint remains ≥700 cm³ spared from 15 Gy 1, 4

Critical Planning Pitfalls

Avoid these common errors:

1. Focusing solely on mean liver dose: The volumetric constraint (cm³ receiving <15-18 Gy) is more predictive of hepatic decompensation than mean dose alone 2

2. Ignoring total liver volume: Patients with smaller total liver volumes (<1,162 cm³) are at significantly higher risk of toxicity even if percentage-based constraints are met 3

3. Inadequate margin for liver motion: Use 4D-CT for treatment planning to account for respiratory motion, as inadequate margins may result in higher actual liver doses than planned 4

Tumor Location Considerations

Tumor location significantly impacts achievable liver sparing:

• Dome or central tumors ≥3 cm: Consider proton therapy if available, as photon plans may struggle to meet liver constraints while maintaining target coverage 5
• Peripheral tumors: Generally easier to spare adequate liver volume with standard photon SBRT
• Multiple lesions: Sequential treatment of different liver regions preferred over simultaneous treatment to preserve liver function 1

Planning Strategy

Step-by-step approach:

1. Contour total liver volume and calculate uninvolved liver (total liver minus GTV)
2. Verify minimum volumes: Confirm total liver >1,162 cm³ and uninvolved liver >1,148 cm³
3. Set primary constraint: ≥800 cm³ of liver receiving <18 Gy (or ≥700 cm³ <15 Gy as minimum)
4. Optimize plan to maximize dose to tumor while respecting liver constraint
5. If constraints cannot be met: Consider dose de-escalation, increased fractionation, or alternative modality (protons) rather than compromising liver sparing 1

When Constraints Cannot Be Met

If standard constraints prove unachievable:

• Increase fractionation: Move from 3 to 5 fractions to allow better liver sparing
• Reduce prescription dose: Prioritize liver preservation over maximal tumor dose in Child-Pugh A patients
• Consider alternative modalities: Proton therapy for central/dome lesions ≥3 cm 5
• Functional liver avoidance planning: Use SPECT imaging to identify and preferentially spare functioning liver tissue 6

The evidence consistently demonstrates that volumetric liver sparing (≥700-800 cm³ receiving <15-18 Gy) is the most critical constraint for preventing hepatic decompensation in Child-Pugh A patients receiving SBRT 1, 2. This constraint takes absolute priority over achieving maximal tumor dose, as hepatic failure eliminates all future treatment options and directly impacts survival.